Dactinomycin for Injection

Active Ingredients: Dactinomycin

Dactinomycin for Injection is an antineoplastic drug used in cancer chemotherapy. It is used to treat some solid tumors, such as Ewing sarcoma. This drug can be used alone or as a combination therapy to treat gestational trophoblastic neoplasia and recurrent or locoregional solid malignancies.

The active ingredient, Dactinomycin, is classified as an antitumor antibiotic. It works by slowing down or stopping the growth of cancer cells in the body by blocking topoisomerase 2, an enzyme needed by cancer cells.

Dactinomycin is also called “actinomycin D”.

AdvaCare Pharma is a producer and exporter of Dactinomycin for Injection. This medicine is produced in our GMP-certified facilities in China, India, and the USA. These facilities are routinely audited to ensure they comply with health, safety, and environmental standards.

AdvaCare Pharma manufactures a variety of oncology medications, including Dactinomycin for Injection, at GMP-certified facilities. We are committed to producing cost-effective, high-quality cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. Our global reach extends to over 65 markets, where we supply our products to distributors, hospitals, pharmacies, NGOs, and government institutions.

What is Dactinomycin used for?

When combined with Methotrexate, this drug is used to treat gestational trophoblastic neoplasia.

How should Dactinomycin Powder be used?

This medication has been manufactured as a powder, which is stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a muscle or vein.

As Dactinomycin for Injection is a cytotoxic drug, caution should be used when preparing and administering the solution. Goggles, gloves, and protective gowns are recommended

What dose should be given?

For Wilms tumor, the usual dose is 45 mcg/kg IV as part of a multi-drug chemotherapy.

The usual dose for adults and children depends on the type of disease and the patient's general condition. Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

As with all pharmaceuticals, some unwanted effects can occur from treatment with Dactinomycin for Injection. Always consult a doctor or healthcare professional for medical advice before beginning treatment.

For a comprehensive list of all possible effects, consult a doctor.

If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor immediately.

The use of Dactinomycin during pregnancy or breastfeeding should be avoided, as Dactinomycin is harmful to the fetus or baby. Consult a doctor or healthcare professional before treatment.

Consult with your doctor about any medications you are taking before beginning treatment with Dactinomycin.